tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ELTX Stock Latest News

Elicio Therapeutics: Promising Trial Results and Commercial Potential Drive Buy Rating
RatingsElicio Therapeutics: Promising Trial Results and Commercial Potential Drive Buy Rating
3d ago
ELTX
Elicio Therapeutics price target raised to $13 from $10 at H.C. Wainwright
PremiumThe Fly
Elicio Therapeutics price target raised to $13 from $10 at H.C. Wainwright
3d ago
ELTX
Elicio Therapeutics to host virtual KOL event on AMP-powered ELI-002
PremiumThe Fly
Elicio Therapeutics to host virtual KOL event on AMP-powered ELI-002
1M ago
ELTX
Elicio Therapeutics Secures $10M Financing for Operations
PremiumCompany Announcements
Elicio Therapeutics Secures $10M Financing for Operations
2M ago
8K
ELTX
Elicio Therapeutics secures $10M in financing
PremiumThe Fly
Elicio Therapeutics secures $10M in financing
2M ago
ELTX
Elicio Therapeutics Elects New Directors at Annual Meeting
PremiumCompany AnnouncementsElicio Therapeutics Elects New Directors at Annual Meeting
2M ago
8K
ELTX
Elicio Therapeutics reports Q1 EPS (87c), consensus (83c)
Premium
The Fly
Elicio Therapeutics reports Q1 EPS (87c), consensus (83c)
2M ago
ELTX
Seven new option listings and one option delisting on April 16th
Premium
The Fly
Seven new option listings and one option delisting on April 16th
3M ago
AVTX
CARA
Elicio Therapeutics: Buy Rating Backed by Financial Stability and Promising ELI-002 7P Developments
PremiumRatings
Elicio Therapeutics: Buy Rating Backed by Financial Stability and Promising ELI-002 7P Developments
4M ago
ELTX
Elicio Therapeutics Advances Cancer Immunotherapy Pipeline
PremiumCompany Announcements
Elicio Therapeutics Advances Cancer Immunotherapy Pipeline
4M ago
ELTX
Elicio Therapeutics reports FY24 EPS ($4.25) vs ($6.96) last year
PremiumThe Fly
Elicio Therapeutics reports FY24 EPS ($4.25) vs ($6.96) last year
4M ago
ELTX
ELTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ELTX Earnings this Week: How Will it Perform?
4M ago
ELTX
Elicio Therapeutics Appoints New Chief Strategy and Financial Officer
PremiumCompany AnnouncementsElicio Therapeutics Appoints New Chief Strategy and Financial Officer
4M ago
8K
ELTX
Elicio Therapeutics appoints Preetam Shah as chief strategy, financial officer
Premium
The Fly
Elicio Therapeutics appoints Preetam Shah as chief strategy, financial officer
4M ago
CDTX
ELTX
Elicio Therapeutics prices 1.26M shares at $7.925 in registered direct offering
Premium
The Fly
Elicio Therapeutics prices 1.26M shares at $7.925 in registered direct offering
6M ago
ELTX
Elicio Therapeutics Advances with New Clinical Updates
PremiumCompany Announcements
Elicio Therapeutics Advances with New Clinical Updates
6M ago
8K
ELTX
Elicio reaches alignment with FDA on ELI-002 registrational strategy
PremiumThe Fly
Elicio reaches alignment with FDA on ELI-002 registrational strategy
6M ago
ELTX
Elicio Therapeutics Advances ELI-002 and Secures Funding
PremiumCompany Announcements
Elicio Therapeutics Advances ELI-002 and Secures Funding
7M ago
8K
ELTX
Elicio Therapeutics presents updated results from ELI-002 Phase 1 study
PremiumThe Fly
Elicio Therapeutics presents updated results from ELI-002 Phase 1 study
7M ago
ELTX
Elicio Therapeutics announces completion of Phase 2 AMPLIFY-7P study enrollment
PremiumThe FlyElicio Therapeutics announces completion of Phase 2 AMPLIFY-7P study enrollment
8M ago
ELTX
Elicio Therapeutics reports Q3 EPS ($1.39), consensus (73c)
Premium
The Fly
Elicio Therapeutics reports Q3 EPS ($1.39), consensus (73c)
8M ago
ELTX
Elicio Therapeutics files to sell 3.44M shares of common stock for holders
Premium
The Fly
Elicio Therapeutics files to sell 3.44M shares of common stock for holders
8M ago
ELTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >